Nexentis Technologies Inc. — Company profile
Consumer Staples · Household & Personal Products · Israel
Last price 0.631 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 917.05K
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company’s pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
Details
| Name | Nexentis Technologies Inc. |
| Sector | Materials |
| Industry | Agricultural Inputs |
| Employees | 9 |
| Founded | 2009 |
| Ceo | David Palach |
| Country | Israel |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US80512Q6008 |
| Cusip | 80512Q600 |
| Cik | 0001789192 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| David Palach | Chief Executive Officer |
| Lital Barda | Chief Financial Officer, Financial Controller, Treasurer and Secretary |
| Galit Kenigsberg | Head of Sustainability Operations of scientific advisory board |
Contact
| Address | Pinhas Sapir St. 3, Kiryat HaMada, Ness Ziona, 7403626, Israel |
| Phone | 972 347 468 9583 |
| Website | https://www.nexentistech.com |